Kymera Therapeutics, Inc.
KYMR
$30.03
$0.010.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 463.15M | 488.74M | 549.97M | 509.95M | 520.54M |
| Total Receivables | 20.00M | 947.00K | 1.32M | 1.70M | 2.03M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 17.80M | 20.58M | 17.43M | 13.75M | 14.68M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 500.95M | 510.27M | 568.72M | 525.41M | 537.25M |
|
|
|||||
| Total Current Assets | 500.95M | 510.27M | 568.72M | 525.41M | 537.25M |
| Net Property, Plant & Equipment | 95.91M | 97.86M | 99.31M | 100.44M | 98.67M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.12M | 7.74M | 5.78M | 7.73M | 7.94M |
| Total Assets | 918.31M | 978.04M | 1.03B | 826.02M | 868.25M |
|
|
|||||
| Total Accounts Payable | 10.26M | 5.99M | 6.49M | 6.51M | 6.81M |
| Total Accrued Expenses | 23.12M | 34.87M | 26.53M | 23.78M | 16.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.24M | 13.11M | 12.85M | 12.42M | 9.89M |
| Total Finance Division Other Current Liabilities | 12.37M | 13.80M | 20.66M | 19.44M | 23.44M |
| Total Other Current Liabilities | 12.37M | 13.80M | 20.66M | 19.44M | 23.44M |
| Total Current Liabilities | 58.99M | 67.77M | 66.53M | 62.14M | 56.14M |
|
|
|||||
| Total Current Liabilities | 58.99M | 67.77M | 66.53M | 62.14M | 56.14M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 73.09M | 74.65M | 75.38M | 75.77M | 77.13M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 3.19M | 23.78M |
| Total Liabilities | 132.08M | 142.42M | 141.91M | 141.10M | 157.05M |
|
|
|||||
| Common Stock & APIC | 1.61B | 1.59B | 1.57B | 1.31B | 1.29B |
| Retained Earnings | -820.19M | -754.61M | -683.86M | -621.37M | -579.31M |
| Treasury Stock & Other | -58.00K | -1.49M | 1.93M | -2.10M | -1.78M |
| Total Common Equity | 786.23M | 835.62M | 892.93M | 684.92M | 711.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 786.23M | 835.62M | 892.93M | 684.92M | 711.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 786.23M | 835.62M | 892.93M | 684.92M | 711.20M |
|
|
|||||